免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版)

2020-11-20 中国抗癌协会 中国肿瘤临床.2020.47(20):1027-1038.

免疫检查点抑制剂(immune checkpoint inhibitors,ICIs)为肿瘤患者带来显著生存获益的同时,其致命性的药物相关心肌炎并发症成为临床中的新挑战。本共识总结ICIs相关心肌炎的

中文标题:

免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版)

发布机构:

中国抗癌协会

发布日期:

2020-11-20

简要介绍:

免疫检查点抑制剂(immune checkpoint inhibitors,ICIs)为肿瘤患者带来显著生存获益的同时,其致命性的药物相关心肌炎并发症成为临床中的新挑战。本共识总结ICIs相关心肌炎的流行病学、病理特点、临床特点、诊断与鉴别诊断、临床分型和对应管理方案,提出主动监测策略(proactive monitoring strategy,PMS)以发现早期心肌损伤,为ICIs相关心肌炎的监测和管理提供指导意见和建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=免疫检查点抑制剂相关心肌炎监测与管理中国专家共识_2020版_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e754f1c00203ae43, title=免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版), enTitle=, guiderFrom=中国肿瘤临床.2020.47(20):1027-1038., authorId=0, author=, summary=免疫检查点抑制剂(immune checkpoint inhibitors,ICIs)为肿瘤患者带来显著生存获益的同时,其致命性的药物相关心肌炎并发症成为临床中的新挑战。本共识总结ICIs相关心肌炎的, cover=https://img.medsci.cn/20201231/1609347218416_2020535.jpg, journalId=0, articlesId=null, associationId=18, associationName=中国抗癌协会, associationIntro=中国抗癌协会是中国科学技术协会主管、中华人民共和国民政部注册登记、具有独立法人资格的肿瘤学科唯一的国家一级学会。成立以来积极开展肿瘤学科的临床与基础性研究,创建肿瘤专业继续教育基地,创办多种形式的肿瘤学习培训班,积极推广新成果、新技术,举办国内外肿瘤学术会议,为国内外肿瘤研究者提供了广阔的学术交流平台,促进了我国肿瘤防治水平的提高。, copyright=0, guiderPublishedTime=Fri Nov 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>免疫检查点抑制剂(immune checkpoint inhibitors,ICIs)为肿瘤患者带来显著生存获益的同时,其致命性的药物相关心肌炎并发症成为临床中的新挑战。本共识总结ICIs相关心肌炎的流行病学、病理特点、临床特点、诊断与鉴别诊断、临床分型和对应管理方案,提出主动监测策略(proactive monitoring strategy,PMS)以发现早期心肌损伤,为ICIs相关心肌炎的监测和管理提供指导意见和建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=36163, tagName=免疫检查点抑制剂)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=36163, guiderKeyword=免疫检查点抑制剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3378, appHits=299, showAppHits=0, pcHits=982, showPcHits=3077, likes=2, shares=48, comments=11, approvalStatus=1, publishedTime=Thu Dec 31 01:13:23 CST 2020, publishedTimeString=2020-11-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Dec 31 00:53:44 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:39:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=免疫检查点抑制剂相关心肌炎监测与管理中国专家共识_2020版_.pdf)])
免疫检查点抑制剂相关心肌炎监测与管理中国专家共识_2020版_.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1249549, encodeId=652012495494f, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:49 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085029, encodeId=63e71085029c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d65631907, createdName=ms9000001438010626, createdTime=Tue Dec 28 09:49:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972679, encodeId=7c3d9e2679f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200917/3b1b95f5f3d9481cbb07d517357a08b6/cfee6506fbee4c75978cc357d4472657.jpg, createdBy=cba85419190, createdName=络, createdTime=Thu Jun 10 22:14:31 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970208, encodeId=7c389e02082a, content=🤔🤔学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIorOtCFyzvcicsOjb058E351icF6kVXia0ibuLqUJgOJC3KgelAFzmxQO3UZg0qfRyED4FpXLgfnROibQ/132, createdBy=ac292566504, createdName=小小665, createdTime=Wed Jun 02 01:24:53 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916198, encodeId=f69c91619839, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIqlnCibWjuDUAgaCHwFuMzAuMjyriarZStfbH4awkBQFoYtqff6tfJDz5D2lgbIicHCJXZxibs2Jr52Q/132, createdBy=c3db5138446, createdName=1466f1b5m86(暂无昵称), createdTime=Wed Jan 13 11:47:28 CST 2021, time=2021-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1249549, encodeId=652012495494f, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:49 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085029, encodeId=63e71085029c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d65631907, createdName=ms9000001438010626, createdTime=Tue Dec 28 09:49:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972679, encodeId=7c3d9e2679f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200917/3b1b95f5f3d9481cbb07d517357a08b6/cfee6506fbee4c75978cc357d4472657.jpg, createdBy=cba85419190, createdName=络, createdTime=Thu Jun 10 22:14:31 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970208, encodeId=7c389e02082a, content=🤔🤔学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIorOtCFyzvcicsOjb058E351icF6kVXia0ibuLqUJgOJC3KgelAFzmxQO3UZg0qfRyED4FpXLgfnROibQ/132, createdBy=ac292566504, createdName=小小665, createdTime=Wed Jun 02 01:24:53 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916198, encodeId=f69c91619839, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIqlnCibWjuDUAgaCHwFuMzAuMjyriarZStfbH4awkBQFoYtqff6tfJDz5D2lgbIicHCJXZxibs2Jr52Q/132, createdBy=c3db5138446, createdName=1466f1b5m86(暂无昵称), createdTime=Wed Jan 13 11:47:28 CST 2021, time=2021-01-13, status=1, ipAttribution=)]
    2021-12-28 ms9000001438010626

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1249549, encodeId=652012495494f, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:49 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085029, encodeId=63e71085029c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d65631907, createdName=ms9000001438010626, createdTime=Tue Dec 28 09:49:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972679, encodeId=7c3d9e2679f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200917/3b1b95f5f3d9481cbb07d517357a08b6/cfee6506fbee4c75978cc357d4472657.jpg, createdBy=cba85419190, createdName=络, createdTime=Thu Jun 10 22:14:31 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970208, encodeId=7c389e02082a, content=🤔🤔学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIorOtCFyzvcicsOjb058E351icF6kVXia0ibuLqUJgOJC3KgelAFzmxQO3UZg0qfRyED4FpXLgfnROibQ/132, createdBy=ac292566504, createdName=小小665, createdTime=Wed Jun 02 01:24:53 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916198, encodeId=f69c91619839, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIqlnCibWjuDUAgaCHwFuMzAuMjyriarZStfbH4awkBQFoYtqff6tfJDz5D2lgbIicHCJXZxibs2Jr52Q/132, createdBy=c3db5138446, createdName=1466f1b5m86(暂无昵称), createdTime=Wed Jan 13 11:47:28 CST 2021, time=2021-01-13, status=1, ipAttribution=)]
    2021-06-10

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1249549, encodeId=652012495494f, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:49 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085029, encodeId=63e71085029c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d65631907, createdName=ms9000001438010626, createdTime=Tue Dec 28 09:49:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972679, encodeId=7c3d9e2679f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200917/3b1b95f5f3d9481cbb07d517357a08b6/cfee6506fbee4c75978cc357d4472657.jpg, createdBy=cba85419190, createdName=络, createdTime=Thu Jun 10 22:14:31 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970208, encodeId=7c389e02082a, content=🤔🤔学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIorOtCFyzvcicsOjb058E351icF6kVXia0ibuLqUJgOJC3KgelAFzmxQO3UZg0qfRyED4FpXLgfnROibQ/132, createdBy=ac292566504, createdName=小小665, createdTime=Wed Jun 02 01:24:53 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916198, encodeId=f69c91619839, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIqlnCibWjuDUAgaCHwFuMzAuMjyriarZStfbH4awkBQFoYtqff6tfJDz5D2lgbIicHCJXZxibs2Jr52Q/132, createdBy=c3db5138446, createdName=1466f1b5m86(暂无昵称), createdTime=Wed Jan 13 11:47:28 CST 2021, time=2021-01-13, status=1, ipAttribution=)]
    2021-06-02 小小665

    🤔🤔学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1249549, encodeId=652012495494f, content=<a href='/topic/show?id=0de5290588c' target=_blank style='color:#2F92EE;'>#免疫检查点抑制剂#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29058, encryptionId=0de5290588c, topicName=免疫检查点抑制剂)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Sat Sep 17 06:48:49 CST 2022, time=2022-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085029, encodeId=63e71085029c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d65631907, createdName=ms9000001438010626, createdTime=Tue Dec 28 09:49:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972679, encodeId=7c3d9e2679f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200917/3b1b95f5f3d9481cbb07d517357a08b6/cfee6506fbee4c75978cc357d4472657.jpg, createdBy=cba85419190, createdName=络, createdTime=Thu Jun 10 22:14:31 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970208, encodeId=7c389e02082a, content=🤔🤔学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIorOtCFyzvcicsOjb058E351icF6kVXia0ibuLqUJgOJC3KgelAFzmxQO3UZg0qfRyED4FpXLgfnROibQ/132, createdBy=ac292566504, createdName=小小665, createdTime=Wed Jun 02 01:24:53 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916198, encodeId=f69c91619839, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIqlnCibWjuDUAgaCHwFuMzAuMjyriarZStfbH4awkBQFoYtqff6tfJDz5D2lgbIicHCJXZxibs2Jr52Q/132, createdBy=c3db5138446, createdName=1466f1b5m86(暂无昵称), createdTime=Wed Jan 13 11:47:28 CST 2021, time=2021-01-13, status=1, ipAttribution=)]
    2021-01-13 1466f1b5m86(暂无昵称)

    学习中

    0

拓展阅读

免疫检查点抑制剂相关血液毒性处理的临床诊疗建议

中国肿瘤科相关专家小组(统称) · 2019-10-30

免疫检查点抑制剂相关肾脏不良反应的临床诊治建议

国外肿瘤科相关专家小组(统称) · 2019-10-30

免疫检查点抑制剂相关皮肤不良反应诊治建议

中国肿瘤科相关专家小组(统称) · 2019-10-25

免疫检查点抑制剂相关神经系统不良反应的临床诊治建议

中国肿瘤科相关专家小组(统称) · 2019-10-30

免疫检查点抑制剂相关消化系统不良反应的临床诊治建议

中国肿瘤科相关专家小组(统称) · 2019-10-30